1509TiP - Randomized phase II trial of osimertinib with or without local consolidation therapy (LCT) for patients with EGFR-mutant metastatic NSCLC (NORTHSTAR)
In: Annals of Oncology, Jg. 29 (2018-10-01), Heft Supplement 8, S. 1
Online
academicJournal
Zugriff:
Titel: |
1509TiP - Randomized phase II trial of osimertinib with or without local consolidation therapy (LCT) for patients with EGFR-mutant metastatic NSCLC (NORTHSTAR)
|
---|---|
Autor/in / Beteiligte Person: | Elamin, Y.Y. ; Antonoff, M. ; Blakely, C. ; Baggstorm, M. ; Bivona, T. ; Le, X. ; Louie, A.V. ; Doebele, R.C. ; Rusthoven, C. ; Lee, P. ; Govindan, R. ; Swisher, S.G. ; Papadimitrakopoulou, V.A. ; Heymach, J.V. ; Gomez, D.R. |
Link: | |
Zeitschrift: | Annals of Oncology, Jg. 29 (2018-10-01), Heft Supplement 8, S. 1 |
Veröffentlichung: | 2018 |
Medientyp: | academicJournal |
ISSN: | 0923-7534 (electronic) |
DOI: | 10.1093/annonc/mdy292.130 |
Sonstiges: |
|